GS
GILEAD SCIENCES INC
GILD· Health Care· BiotechnologyS&P 500
Close · 13/11/2026
168.08
1D
+0.08%52-week range
116.88 – 176.58
Volume
36,37,400.00
Price history
GILD
15/10/2026 to 13/11/2026
O 168.58 H 169.12 L 166.94
1W+0.71%
1M+6.81%
3M+20.99%
6M+29.71%
1Y+36.21%
3Y+115.76%
5Y+153.44%
MAX+136.23%
Fundamentals
as of 13/11/2026- Market cap
- $208.48B
- Shares out
- 1.24B
- P/E (forward)
- 16.59
- EPS (trailing)
- -3.11
- Dividend yield
- 1.93%
- Beta
- 0.37
- Profit margin
- -12.47%
- P/B
- 15.99
- Return on equity
- -29.62%
SEC financial statements
68 quarterly and 19 annual periods through 30/09/2026.
Details
- Ticker
- GILD
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 13/11/2026.
Tracked by Congress
11 filers · 2 on watchlist · 22 buys · 10 sells · 7 options · ?: 3 · D: 11 · R: 18
- 10/05/2024Thomas H TubervilleWBuyoption on GILD$1,001–$15,000
- 10/05/2024Thomas H TubervilleWBuyoption on GILD$1,001–$15,000
- 10/05/2024Thomas H TubervilleWBuyoption on GILD$1,001–$15,000
- 08/05/2024Thomas H TubervilleWSellGilead Sciences, Inc. - Common Stock$1,001–$15,000
- 27/03/2026Alan ArmstrongBuyGilead Sciences, Inc. - Common Stock$1,001–$15,000
- 06/05/2026Jared MoskowitzBuyGilead Sciences, Inc. - Common Stock$1,001–$15,000
- 06/05/2026Jared MoskowitzBuyGilead Sciences, Inc. - Common Stock$1,001–$15,000
- 27/01/2026Josh GottheimerWBuyGilead Sciences, Inc. - Common Stock$1,001–$15,000